ST LOUIS, May 12 /PRNewswire-FirstCall/ -- Stereotaxis, Inc. announced today the introduction of new technology to be highlighted at the Heart Rhythm 2006 Scientific Sessions. Key capabilities include: automated cardiac chamber mapping, computer aided linear navigation, a fully integrated 3D localization system, and a simple user interface and wand control system.
The Company's remote magnetic navigation technology will be the subject of 11 separate sessions in a combination of live case presentations, sponsored symposia, oral abstracts and poster presentations at Heart Rhythm 2006, the Heart Rhythm Society's 27th Annual Scientific Sessions at the Boston Convention and Exhibition Center in Boston, Massachusetts from Wednesday, May 17th through Saturday, May 20th. In addition, Stereotaxis will demonstrate the unique clinical utility and precision of remote magnetic navigation technology at Booth #227. Physicians will have an opportunity to test drive the system by navigating catheters in St Louis at our headquarters from the booth in Boston.
Key scientific events will include: Special Sessions: Live and Edited Ablations of Atrial Fibrillation - Live Remote Procedure Carlo Pappone, MD, PhD., et al., Hospital San Raffaele, Milan, Italy, May 17th at 11AM ET Remote Catheter Navigation for Ablation Sabine Ernst MD, St Georg General Hosp., Hamburg, Germany Sponsored Symposia: Management of Complex Arrhythmias Jeremy N. Ruskin, MD; Francis E. Marchlinski, MD; Michel Haissaguerre, MD; Carlo Pappone, MD; Koonlawee Nademanee, MD; Gery Tomassoni, MD; Douglas L. Packer, MD Oral Abstract Presentations: Initial Experience with Left Ventricular Lead Placement Using remote Magnetic Navigation and High Speed Rotational Coronary Sinus Angiography., Patel et al., St. Elizabeth's Medical Center, Boston, MA Fast-Track Determination of Best CRT Lead Positioning by Stereotaxis and Left Ventricular Pressure-Volume and Dyssynchrony Analysis., Schreuder et al., San Raffaele University Hospital, Milan, Italy Magnetically Guided Remote Navigation for Atrial Fibrillation Ablation: The Milan Experience., Pappone et al., San Raffaele University Hospital, Milan, Italy Deciphering Technologies in EP: The Principles and Applications., Mark A Wood MD., Virginia Commonwealth University Medical Center, Richmond, VA Robotic Versus Manual Navigation: Is It Worth your Bucks?, Walid I Saliba MD., Cleveland Clinic, Cleveland, OH Poster Presentations: Magnetically Guided Ablation for AV Node Reentrant Tachycardia. Results from a Prospective Study in 139 Patients., Pappone et al., Hospital San Raffaele, Milan, Italy Magnetic Catheter Navigation is Safe and Effective for Ablation of Supraventricular Tachycardia: Results of the Multi-Center ATTRAC Study., Lindsay et al. Initial Experience with Remote Magnetic Navigation for Left Ventricular Lead Placement., Mischke et al., Aachen University, Aachen, Germany Catheter Ablation of Supraventricular Tachycardia Using the Magnetic Navigation System: A Comparison of Two Different Diagnostic Strategies., Ernst et al., St Georg General Hospital, Hamburg, Germany Successful Ablation of a Concealed Parahisian Accessory Pathway Using remote Control Magnetic Navigation Following Failure of Conventional Methods., Davis et al., University of Ottawa Heart Institute, Ottawa, ON, Canada Remote Catheter Mapping and Ablation of Kent Bundle in Patients with Previous Failed Procedure., Pappone et al., San Raffaele University Hospital, Milan, Italy
Heart Rhythm Society, incorporated in 1979, has a membership of approximately 3,500 physicians and associated professionals from the United States, Canada, Mexico and many other countries. Heart Rhythm Society is the dominant professional group representing the allied specialties of cardiac pacing and cardiac electrophysiology in North America and plays an important role not only in education but also as an intermediary between government regulatory agencies and members of the profession.
About Stereotaxis
Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias. The Stereotaxis System is designed to enable physicians to complete more complex interventional procedures by providing image guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. This is achieved using computer-controlled, externally applied magnetic fields that govern the motion of the working tip of the catheter or guidewire, resulting in improved navigation, shorter procedure time and reduced x-ray exposure. The core components of the Stereotaxis system have received regulatory clearance in the U.S., Europe and Canada.
This press release includes statements that may constitute "forward- looking" statements, usually containing the words "believe," "estimate," "project," "expect" or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance of the Company's products in the marketplace, competitive factors, changes in government reimbursement procedures, dependence upon third-party vendors, and other risks discussed in the Company's periodic and other filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release. There can be no assurance that we will recognize revenue related to our purchase orders and other commitments in any particular period or at all because some of these purchase orders and other commitments are subject to contingencies that are outside of our control. In addition, these orders and commitments may be revised, modified or canceled, either by their express terms, as a result of negotiations, or by project changes or delays.
Contacts: Stereotaxis, Inc. Noonan Russo 314-678-6105 212-845-4269 Jim Stolze, Chief Financial Officer Brian Ritchie (investors) jstolze@stereotaxis.combrian.ritchie@eurorscg.com
Stereotaxis, Inc.CONTACT: Jim Stolze, Chief Financial Officer of Stereotaxis, Inc.,+1-314-678-6105, jstolze@stereotaxis.com; or Investors: Brian Ritchie ofNoonan Russo, +1-212-845-4269, brian.ritchie@eurorscg.com, for Stereotaxis,Inc.
